Dyspigmentation: Causes, Symptoms and Treatment

What is Dyspigmentation?

Dyspigmentation is an umbrella term for all conditions involving abnormal skin pigmentation. The pigment melanin, produced by specialized skin cells called melanocytes, is the primary determinant of skin, hair, and eye color. When melanin production is disrupted, areas of skin may become abnormally light (hypopigmentation) or abnormally dark (hyperpigmentation). Dyspigmentation can have a significant cosmetic impact and may, in some cases, indicate an underlying medical condition requiring treatment.

Causes

Dyspigmentation has a wide range of causes, including genetic, environmental, and systemic factors:

• UV radiation: Chronic sun exposure is one of the most common triggers for hyperpigmentation, leading to conditions such as age spots (solar lentigines).
• Hormonal changes: Pregnancy and the use of oral contraceptives can trigger melasma (also called chloasma), characterized by patchy darkening of the face.
• Post-inflammatory changes: Skin conditions such as acne, eczema, or other inflammatory disorders can leave behind post-inflammatory hyperpigmentation (PIH).
• Autoimmune disease: In vitiligo, the immune system attacks and destroys melanocytes, leading to white, depigmented patches.
• Genetic factors: Conditions such as albinism result from a congenital absence or severe reduction of melanin.
• Medications and chemicals: Certain drugs (e.g., chemotherapeutic agents, some antibiotics) or occupational chemical exposure can induce pigment changes.
• Metabolic and systemic diseases: Conditions such as Addison disease (adrenal insufficiency) can cause widespread hyperpigmentation.

Types and Symptoms

Hyperpigmentation

Hyperpigmentation refers to areas of skin that are darker than the surrounding tissue. Common manifestations include:

• Melasma: Symmetrical, brown to gray-brown patches, predominantly on the face
• Solar lentigines: Small, well-defined brown spots commonly known as age spots or liver spots
• Post-inflammatory hyperpigmentation: Dark discoloration remaining after skin injury or inflammation
• Cafe-au-lait spots: Light brown, oval macules that may be associated with genetic syndromes

Hypopigmentation

Hypopigmentation occurs when melanin is reduced or absent in certain skin areas, resulting in lightening:

• Vitiligo: Well-defined, milky-white patches of depigmented skin
• Pityriasis alba: Faint, slightly scaly pale patches, most commonly seen in children
• Albinism: Congenital, complete or partial absence of melanin affecting the skin, hair, and eyes

Diagnosis

Dyspigmentation is typically diagnosed and evaluated by a dermatologist. The following methods are commonly used:

• Clinical examination: Assessment of lesion shape, color, distribution, and borders
• Wood lamp examination: A UV lamp that helps differentiate superficial from deep pigment changes
• Dermatoscopy: Magnified examination of the skin for more detailed lesion assessment
• Skin biopsy: Tissue sampling for microscopic analysis in unclear or suspicious cases
• Laboratory tests: Blood work to rule out underlying conditions such as hormonal or autoimmune disorders

Treatment

Treatment depends on the specific type and underlying cause of dyspigmentation:

Topical Treatments

• Hydroquinone: A depigmenting agent that inhibits melanin synthesis (available by prescription in many countries)
• Azelaic acid and kojic acid: Tyrosinase inhibitors that lighten pigmented areas
• Retinoids (Vitamin A derivatives): Promote skin cell turnover and reduce pigment spots
• Corticosteroids: Used in combination therapies for inflammation-related pigment disorders

Physical and Light-Based Treatments

• Laser therapy: Targeted treatment of pigmented lesions using specialized lasers (e.g., Q-switched Nd:YAG laser)
• Intense Pulsed Light (IPL): Broadband light therapy for age spots and melasma
• Chemical peels: Removal of superficial skin layers to reduce pigment changes
• Microdermabrasion: Mechanical exfoliation of the skin surface

Treatment of the Underlying Condition

When dyspigmentation is caused by a systemic disease (e.g., hormonal disorder, autoimmune condition), treating the root cause is the primary approach. For vitiligo, options include phototherapy (narrowband UVB, PUVA) and immunomodulatory agents such as tacrolimus.

Sun Protection

Consistent use of broad-spectrum sunscreen (SPF 30 or higher) is essential for virtually all forms of dyspigmentation to prevent worsening and to support treatment outcomes.

Prevention

Many acquired forms of dyspigmentation can be minimized or prevented through targeted measures:

• Regular and adequate sun protection (sunscreen, protective clothing, avoiding peak sun hours)
• Gentle skincare routines to minimize skin inflammation
• Using hormonal medications only under medical supervision
• Early dermatological evaluation of newly appearing pigment changes

References

1. Krutmann J. et al. - Photodermatology, Photoimmunology and Photomedicine. Wiley-Blackwell, 2014.
2. Passeron T. et al.: Hyperpigmentation disorders. In: Journal of the European Academy of Dermatology and Venereology, 2017; 31 Suppl 5: 1-19.
3. Rodrigues M. et al.: Melasma. In: Journal of the American Academy of Dermatology, 2022; 86(5): 1009-1022.